Ongoing Clinical Trials in BRAF-Mutant CRC
Автор: Targeted Onc
Загружено: 2018-01-15
Просмотров: 205
Описание:
Cathy Eng, MD, FACP, professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, discusses ongoing clinical trials in the BRAF-mutant colorectal cancer patient population.
The most recent study presented for the BRAF-mutant population was SWOG S1406, which looked at a control arm of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer. The study was positive for progression-free survival, which was the primary endpoint.
Eng believes this was an eye-opening study in that it suggests testing patients for the presence of a BRAF mutation and providing patients with a BRAF inhibitor.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: